Biological Chemistry and Drug Discovery (BCDD)
Improving our understanding of pathogen biology and transforming drug discovery for both infectious and non-infectious diseases; making the previously undruggable, druggable.

We target lethal and debilitating pathogens, address urgent unmet patient needs, and deliver new medicines; working in a multi-disciplinary, highly collaborative and well-resourced research environment. Delivery is enabled through technological innovation, research excellence, and partnerships with research and development organisations and pharmaceutical companies.
World-leading centres and teams
BCDD incorporates the following world-leading centres and teams:
- Wellcome Centre for Anti-Infectives Research
A hub for innovation in neglected tropical disease drug discovery. - Drug Discovery Unit
Translates basic science into pre-clinical drug candidates. - Mode-of-Action group
Undertakes drug target deconvolution studies with anti-infective compounds. - Centre for Targeted Protein Degradation
Revolutionising drug discovery by making the previously undruggable, druggable.
Core strengths
Cross-cutting core strengths and innovation areas include:
- drug-resistance
- chemical biology
- glycobiology
- medicinal chemistry
- gene expression control mechanisms
- genetic manipulation
- high-throughput screening
- proteomics
- molecular interactions
- imaging
- informatics
Infectious diseases
Infectious diseases we target include:
- African trypanosomiasis
- leishmaniasis
- Chagas disease
- malaria
- cryptosporidiosis
- cryptococcosis
- schistosomiasis
- tuberculosis
Training and mentoring are embedded at all levels. Several highly successful spinouts and start-ups have attracted major investment.
- Tropical diseases [African trypanosomiasis, leishmaniasis, malaria]
- New approaches to drug discovery [Targeted protein degradation, Exscientia]
Head of Division
person

Academic staff
person

person

person

person

person


person

person

person

person

person

person

person

person

Associates
person

person

person

person

Key contacts
Name | Role | |
---|---|---|
Shona McInroy | Lab Manager | [email protected] |
Jamie Curran | Lab Manager | [email protected] |
Susan Ross | Senior Technical Support | [email protected] |
Kirstie Hughes | PA to Prof Ian Gilbert | [email protected] |
Diane Purves | PA to Prof Alessio Ciulli | [email protected] |
Debbie Tarver | Executive Administrator and Team Leader | [email protected] |
Deborah Moorjani | Secretary | [email protected] |
Professor David Gray | Public Engagement Champion | [email protected] |
Scott Hendry | Senior Technical Support | [email protected] |
Cavan Short | Lab Management Support Technician | [email protected] |
Euan Waugh | Lab Management Support Technician | [email protected] |
Margo Petrie | Senior Division Secretary | [email protected] |
Megan Findlay | Senior Division Secretary | [email protected] |
Paige Nell | Division Secretary | [email protected] |
Publications
Stories
Press release
A leading authority on Cryptosporidium has warned of an urgent need for greater awareness and more fundamental research of the deadly parasite.

News
School of Life Sciences Professor Susan Wyllie and colleagues have been recognized by Drugs for Neglected Diseases Initiative (DNDi) as part of the team awarded DNDi 2024 Project of the Year in pre-clinical research
Press release
Scientists at the University of Dundee have made a significant breakthrough in the quest to eradicate a parasite that blights millions of lives.

News
It has been ten years since the Discovery Centre opened. Professor Sir Mike Ferguson looks back at how the Centre came to fruition and what has taken place since then.
News
Ingo Hein, Jens Januschke, Stephen Land, Marios Stavridis and Susan Wyllie have been promoted to Personal Chair (Professor) as part of the 2023-24 Annual Review process for academic and research staff.

News
Research from the School of Life Sciences hopes to accelerate the drug discovery process by providing key data that will aid in the design of new treatments to combat antimicrobial resistance (AMR).

Press release
Some of Scotland’s brightest business prospects are preparing for an exciting future after being crowned winners of a major Scottish competition.